Advertisement

Topics

Post Capital Partners LLC Company Profile

19:22 EDT 18th June 2018 | BioPortfolio

Post Capital Partners (www.postcp.com) is a private investment firm that makes both minority growth and control investments in companies with a minimum of $10 million of revenue and $2 million of EBITDA. Post Capital primarily employs an “Executive-First” deal sourcing and investment strategy in which they pursue growth capital investments, management buyouts, and “Executive-First” platform searches. Based in New York City, Post Capital invests a committed capital fund with top-tier institutional and sophisticated private investors.


News Articles [1509 Associated News Articles listed on BioPortfolio]

M&As this week: Crescent Capital Partners, IPCA Laboratories Ltd

Crescent Capital Partners has acquired Nucleus Network Ltd from Baker IDI Heart and Diabetes Institute. The sale will help Baker...Read More... The post M&As this week: Crescent Capital Partners, ...

Aptinyx closes $70mm Series B round

Neurology-focused start-up Aptinyx Inc. raised $70mm through a Series B financing round led by new investor Bain Capital Life Sciences, which adds a director to the Aptinyx board. Other new backers in...

Medigene-Aktie: Rückzug von Leerverkäufer GSA Capital Partners hat an Dynamik gewonnen!

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP hat Netto-Leerverkaufsposition in Medigene-Aktien stark verringert: Die Leerverkäufer des Hedgefonds GSA Capital Partners L....

Centrexion raises $67mm in Series D round to fund Phase III trial for pain candidate CNTX4975

Pain-focused Centrexion Therapeutics Corp. raised $67mm in a Series D financing led by New Enterprise Associates. New and returning investors, including Quan Capital, ArrowMark Partners, investment fu...

Honest Buildings Expands Series B Round to $21M with Additional Real Estate-Owner Investments

They join existing Series B industry investors Brookfield Property Partners, Rudin Ventures and C-III Capital Partners, in addition to leading venture capital funds Navitas Capital, Read more...

CStone closes $260mm Series B round; largest in Chinese biopharm history

Immuno-oncology firm CStone Pharmaceuticals Co. Ltd. raised $260mm through its Series B round, the largest funding of its kind in Chinese biopharma history. GIC Private Ltd. led and was joined by new ...

Medigene-Aktie: Leerverkäufer GSA Capital Partners hat den Rückwärtsgang eingelegt!

Martinsried - Leerverkäufer GSA Capital Partners LLP baut Netto-Leerverkaufsposition in Medigene-Aktien etwas ab: Die Leerverkäufer des Hedgefonds GSA Capital Partners LLP haben den Rückwärtsgang ...

TCR2 closes $125mm Series B round

TCR2 Therapeutics Inc. (immuno-oncology) raised $125mm through its Series B round. Curative Ventures and 6 Dimensions Capital co-led and were joined by additional new investors Redmile Group, ArrowMar...

PubMed Articles [1464 Associated PubMed Articles listed on BioPortfolio]

Surgical treatment of femoroacetabular impingement after slipped capital femoral epiphysis.

Femoroacetabular impingement (FAI) post slipped capital femoral epiphysis (SCFE) may lead to degenerative changes on the hip. We have reviewed the current procedures in the literature, aiming to corre...

Impact of first sexual intercourse on the sexual and reproductive life of young people in a capital city of the Brazilian Northeast.

This study aimed to analyze the repercussion of first sexual intercourse on the number of pregnancies and partners of teenagers with obstetric history in Teresina (PI), Brazil. This is a cross-section...

Receiving HIV Serostatus Disclosure from Partners Before Sex: Results from an Online Survey of Chinese Men Who Have Sex with Men.

HIV serostatus disclosure before sex can facilitate serosorting, condom use and potentially decrease the risk of HIV acquisition. However, few studies have evaluated HIV serostatus disclosure from par...

Social capital and PTSD among PLWHA in China: the mediating role of resilience and internalized stigma.

Post-traumatic Stress Disorder (PTSD) is frequent among people living with HIV/AIDS (PLWHA). Few studies have investigated social-psychological predictors of PTSD in China. This study aimed to examine...

Health and social care coordination for severe and persistent mental illness in Australia: a mixed methods evaluation of experiences with the Partners in Recovery Program.

Care coordination has been identified as a person-centred response to the difficulty in meeting the needs of people with severe and persistent mental illness and complex needs. This study evaluated th...

Clinical Trials [2814 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

The Use of HIV Self-tests to Promote Partner and Couples Testing: a Randomized Trial

This randomized controlled trial will explore whether the provision of oral HIV self-test kits to women can increase HIV testing among their male partners. The study will recruit adult wom...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Companies [2245 Associated Companies listed on BioPortfolio]

Post Capital Partners LLC

Post Capital Partners (www.postcp.com) is a private investment firm that makes both minority growth and control investments in companies with a minimum of $10 million of revenue a...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Thompson Street Capital Partners

Thompson Street Capital Partners has $450 million in capital under management. The private equity firm makes investments in manufacturing, service and distribution businesses. The fund's philosophy is...

Amulet Capital Partners, LP

Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long...

Harbinger Capital Partners

Harbinger Capital Partners is a multi-billion dollar private investment fund based in New York which employs a fundamental, intensive research-based approach to investing. ...

More Information about "Post Capital Partners LLC" on BioPortfolio

We have published hundreds of Post Capital Partners LLC news stories on BioPortfolio along with dozens of Post Capital Partners LLC Clinical Trials and PubMed Articles about Post Capital Partners LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Post Capital Partners LLC Companies in our database. You can also find out about relevant Post Capital Partners LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record